Oops. Trump’s ‘Golden Dome’ Cost Skyrockets to $1.2T
A fresh CBO illustrative analysis puts the Golden Dome missile defense at about $1.2 trillion, far above earlier esti...
What Qualifies As Taxable Income For Rewards
Not all rewards are considered taxable income. Discover what qualifies to keep your finances in check and avoid penalties.
12,720 articles
Here's Tesla Stock Before 2031: A Long-Term Buy Signal
Tesla looks different than it did a few years ago. This article explains why here's tesla stock before 2031 might off...
Digimarc (DMRC) 2026 Earnings Outlook: Key Insights
Digimarc's Q1 2026 results shed light on its trajectory for the year. This analysis breaks down revenue, cash flow, a...
Maha Movement Coming School Cafeterias: Costs for Kids
As the maha movement coming school expands into cafeteria menus, districts face higher costs from stricter nutrition ...
Forget Hype: Microsoft Alphabet Vie for AI Crown in 2026
Microsoft and Alphabet laid out contrasting AI roadmaps in late April 2026 earnings, setting up a stock showdown betw...
What Know About This Fund’s Appian Buy Amid AI Growth
A notable fund just built a sizable position in Appian as AI driven automation accelerates. This article breaks down ...
Westport (WPRT) 2025 Earnings Outlook and Insights
Westport's Q4 2025 earnings release offers clues about growth, margins, and cash flow. This article breaks down the t...
Why Professional Fund Managers Lose to the S&P 500
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
Iran Fallout: Qatar Needs Defense Missiles — Quick Guide
Geopolitics in the Gulf is shifting fast. Qatar eyes a $1 billion missiles package from BAE Systems, a move that coul...
NRMLA’s Steve Irwin on What Lenders Face in 2026
NRMLA president Steve Irwin outlines a tougher operating climate for reverse mortgage lenders in 2026, even as tech a...
Ginnie Mae’s Joseph Gormley Warns on FHA Risk Layers
Ginnie Mae’s Joseph Gormley warns that risk-layered FHA portfolios pose new challenges for lenders and investors as l...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status